Alyeska discloses 9.9% stake in Contango ORE (CTGO), 1,481,441 shares

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh filed a Schedule 13G reporting beneficial ownership in Contango ORE (CTGO).

Rhea-AI Filing Summary

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh filed a Schedule 13G reporting beneficial ownership in Contango ORE (CTGO).

The group reports 1,481,441 shares beneficially owned, representing 9.9% of Class A common stock, with shared voting and dispositive power over 1,481,441 shares and no sole power. They certify the holdings were acquired and are held in the ordinary course and not to change or influence control.

An exhibit notes holdings include 1,475,000 shares plus warrants to purchase 40,000 shares and 525,000 pre-funded warrants, subject to a 9.9% Beneficial Ownership Limitation; as of September 30, 2025, only 6,441 shares may be exercised under the warrants. The percentage uses 14,964,048 shares outstanding based on a Form 10-Q filed on November 13, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who filed the Schedule 13G for CTGO?

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh filed the statement.

How many CTGO shares are beneficially owned and what percent of the class is that?

They report beneficial ownership of 1,481,441 shares, representing 9.9% of Class A common stock.

What voting and dispositive power is reported in the 13G?

They report shared voting power: 1,481,441; shared dispositive power: 1,481,441; and 0 for both sole voting and sole dispositive power.

What warrants are held and are there limits on exercise?

They hold warrants to purchase 40,000 shares and 525,000 pre-funded warrants, subject to a 9.9% Beneficial Ownership Limitation; as of September 30, 2025, up to 6,441 shares may be exercised.

What share count was used to calculate the 9.9% ownership?

The calculation assumes 14,964,048 shares outstanding, based on the company’s Form 10-Q filed on November 13, 2025.

What does the certification in the filing state?

The securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control of the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/14/2025 - 05:50 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Contango ORE

(Name of Issuer)

Class A Common Stock, $0.001 par value

(Title of Class of Securities)

21077F100

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 21077F100

1

Names of Reporting Persons

Alyeska Investment Group, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,481,441.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,481,441.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,481,441.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 21077F100

1

Names of Reporting Persons

Alyeska Fund GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,481,441.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,481,441.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,481,441.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 21077F100

1

Names of Reporting Persons

Anand Parekh

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,481,441.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,481,441.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,481,441.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Contango ORE
(b)	Address of issuer's principal executive offices: 516 2ND AVENUE, SUITE 401, FAIRBANKS, AK, 99701
Item 2.
(a)	Name of person filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Fund GP, LLC (iii) Anand Parekh
(b)	Address or principal business office or, if none, residence: (i) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor, Chicago, IL 60601
(c)	Citizenship: (i) Alyeska Investment Group, L.P. - Delaware (ii) Alyeska Fund GP, LLC - Delaware (iii) Anand Parekh - United States of America
(d)	Title of class of securities: Class A Common Stock, $0.001 par value
(e)	CUSIP No.: 21077F100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,481,441
(b)	Percent of class: 9.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 1,481,441
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 1,481,441
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alyeska Investment Group, L.P.

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	11/14/2025

Alyeska Fund GP, LLC

Signature:	Jason Bragg
Name/Title:	Jason Bragg | Chief Financial Officer
Date:	11/14/2025

Anand Parekh

Signature:	Anand Parekh
Name/Title:	Anand Parekh | Self
Date:	11/14/2025

Exhibit Information

The reporting persons are the beneficial owners of 1,475,000 shares of Class A common stock, of the Issuer and hold warrants to purchase 40,000 shares of the Issuer's Class A common stock and 525,000 pre-funded warrants to purchase the Issuer's Class A common Stock (the "Warrants"). However, per their terms, the Warrants can only be exercised into such number of shares that would constitute 9.9% of the total number of Common Stock of the Issuer outstanding immediately after giving effect to the issuance of Common Stock upon exercise of this Warrant by the Holder. Accordingly, as of September 30, 2025 the reporting persons may only exercise up to 6,441 Ordinary Shares under the Warrant Agreement, and as such, is reporting beneficial ownership of only such number of shares. The percentage calculation assumes that there are currently 14,964,048 outstanding shares of Ordinary Shares of the Issuer, based on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 13, 2025. JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.